Microbial cell-free DNA sequencing may identify periprosthetic joint infection pathogens
Click Here to Manage Email Alerts
Published results showed blood microbial cell-free DNA sequencing may accurately identify pathogens and be used to monitor infection clearance during the treatment period among patients with periprosthetic joint infections.
Mathias P. Bostrom, MD, Laura T. Donlin, PhD, and colleagues collected peripheral blood from 53 adults with validated hip or knee periprosthetic joint infections immediately prior to surgical treatment. Researchers sequenced and aligned microbial cell-free DNA from plasma to a genome database with more than 1,000 microbial species, and performed intraoperative tissue and synovial fluid cultures per the standard of care. Researchers considered the accuracy of organism identification with the use of blood cell-free DNA sequencing, as measured by agreement with tissue-culture results, as the primary outcome.
Results showed organisms were identified in 87% of patients by intraoperative and preoperative joint cultures. Researchers found microbial cell-free DNA sequencing identified the joint pathogen in 35 cases, including four of seven culture-negative cases and, as an adjunct to cultures, increased pathogen detection from 87% to 94%. For cases with genus-only culture results, researchers noted a median time to species identification of 3 days less than standard-of-care methods. Additional microorganisms not grown in cultures were detected by circulating cell-free DNA sequencing in 14 cases, according to results. Researchers found no detection or reduced levels of infectious pathogen with cell-free DNA sequencing at postoperative encounters.
Not only can blood microbial cell-free DNA sequencing be used as a screening and adjunct diagnostic test for potential orthopedic infections, but as a means for monitoring the clearance or persistence of an orthopedic infection during treatment, according to Donlin, co-director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery and principal investigator of the study.
“The latter can help in a variety of settings, including during treatment of a prosthetic joint infection by a two-stage surgical procedure wherein the timing of the second stage could be educated by the clearance or lack of clearance of the infection as determined by a mildly invasive blood test,” Donlin told Healio Orthopedics.
Bostrom also noted use of blood microbial cell-free DNA sequencing allows for diagnosis of periprosthetic joint infections without joint aspiration, which is painful and invasive.
“We may also be able to better diagnose infections that involve multiple organisms,” Bostrom, chief of the adult reconstruction and joint replacement service at Hospital for Special Surgery, told Healio Orthopedics. “Ultimately, this test could let us diagnose the presence of an infection before the cultures grow out of the bacteria.”